[go: up one dir, main page]

WO2008034895A3 - dérivés d'ansamycine - Google Patents

dérivés d'ansamycine Download PDF

Info

Publication number
WO2008034895A3
WO2008034895A3 PCT/EP2007/060032 EP2007060032W WO2008034895A3 WO 2008034895 A3 WO2008034895 A3 WO 2008034895A3 EP 2007060032 W EP2007060032 W EP 2007060032W WO 2008034895 A3 WO2008034895 A3 WO 2008034895A3
Authority
WO
WIPO (PCT)
Prior art keywords
derivatives
ansamycin derivatives
ansamycin
diseases
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2007/060032
Other languages
English (en)
Other versions
WO2008034895A2 (fr
Inventor
Friedrich Georg Hansske
Simon Werner
Peter Eckard
Rajendra-Prasad Maskey
Hans-Falk Rasser
Bernd Sontag
Iris Grun-Wollny
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Discovery Partners International GmbH
Original Assignee
Discovery Partners International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Discovery Partners International GmbH filed Critical Discovery Partners International GmbH
Publication of WO2008034895A2 publication Critical patent/WO2008034895A2/fr
Publication of WO2008034895A3 publication Critical patent/WO2008034895A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne de nouveaux dérivés d'ansamycine de Formule (I) ou (II) : des produits médicinaux qui contiennent des dérivés ou des sels de ces dérivés, et l'utilisation de dérivés de geldanamycine pour le traitement de maladies, en particulier des maladies néoplastiques.
PCT/EP2007/060032 2006-09-21 2007-09-21 dérivés d'ansamycine Ceased WO2008034895A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE200610044472 DE102006044472A1 (de) 2006-09-21 2006-09-21 Geldanamycin-Derivate
DE102006044472.8 2006-09-21

Publications (2)

Publication Number Publication Date
WO2008034895A2 WO2008034895A2 (fr) 2008-03-27
WO2008034895A3 true WO2008034895A3 (fr) 2008-05-08

Family

ID=39092807

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/060032 Ceased WO2008034895A2 (fr) 2006-09-21 2007-09-21 dérivés d'ansamycine

Country Status (2)

Country Link
DE (1) DE102006044472A1 (fr)
WO (1) WO2008034895A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109295125B (zh) * 2018-10-08 2020-12-18 中国科学院南海海洋研究所 安莎霉素类化合物及其制备方法与应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005056531A1 (fr) * 2003-11-12 2005-06-23 Kosan Biosciences, Inc. Composes 11-o-methylgeldanamycine
WO2007059116A2 (fr) * 2005-11-14 2007-05-24 Abraxis Bioscience, Inc. Derives de geldanamycine et compositions pharmaceutiques associees

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005056531A1 (fr) * 2003-11-12 2005-06-23 Kosan Biosciences, Inc. Composes 11-o-methylgeldanamycine
WO2007059116A2 (fr) * 2005-11-14 2007-05-24 Abraxis Bioscience, Inc. Derives de geldanamycine et compositions pharmaceutiques associees

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
COWEN, L.E., LINDQUIST, S., SCIENCE, vol. 309, 2005, pages 2185, XP002470935 *
KUMAR R ET AL: "Plasmodium falciparum calcineurin and its association with heat shock protein 90: mechanisms for the antimalarial activity of cyclosporin A and synergism with geldanamycin", MOLECULAR AND BIOCHEMICAL PARASITOLOGY, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 141, no. 1, May 2005 (2005-05-01), pages 29 - 37, XP004823798, ISSN: 0166-6851 *

Also Published As

Publication number Publication date
WO2008034895A2 (fr) 2008-03-27
DE102006044472A1 (de) 2008-04-03

Similar Documents

Publication Publication Date Title
WO2005110994A3 (fr) Derives de pyrazolyl uree substitues utiles dans le traitement du cancer
MY150285A (en) 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
WO2007093880A3 (fr) Nouveaux dérivés d'indolopyrone et leur procédé de préparation
WO2009071690A3 (fr) Dérivés d'oxindole à double substitution en positions 5 et 6 et leur utilisation pour traiter des maladies liées à la vasopressine
WO2009016410A3 (fr) Composés chimiques 831
WO2003080582A3 (fr) Derives de fredericamycine
WO2007064883A3 (fr) Derives substitues de 4-amino-pyrrolotriazine utiles dans le traitement de troubles hyperproliferatifs et de maladies associees a l'angiogenese
WO2009071689A3 (fr) Dérivés d'oxindole substitués par halogène en position 5 et leur utilisation pour traiter des maladies liées à la vasopressine
WO2010067078A3 (fr) Sels de xanthylium disubstitués en 3 et 6
WO2008000483A3 (fr) Composés organiques
EP1937633B8 (fr) Derives d'acide biphenyloxyacetique utilises pour le traitement de maladies respiratoires
MY148723A (en) Use of pinolenic acid for the treatment of obesity
WO2009074247A8 (fr) Nouveaux dérivés d'amide d'acide 2-arylthiazole-4-carboxylique, leur préparation et leur utilisation en tant que médicament
WO2005086656A3 (fr) Derives d'heteroarylaminopyrazole utilises pour traiter le diabete
WO2007131907A3 (fr) Dérivés de 1h-indol-5-yl-pipérazin-1-yl-méthanone
WO2009003719A3 (fr) Dérivés d'indane-amine, leur préparation et leur utilisation comme médicaments
WO2009015369A3 (fr) Composés qui inhibent l'activité de la bêta-sécrétase et procédés d'utilisation de ceux-ci
WO2007009721A3 (fr) Derives de pyrazoline substitues indoline, preparation et utilisation comme medicaments
WO2010042212A3 (fr) Méthodes de traitement prophylactique ou thérapeutique de la douleur à l'aide de dérivés de spicamycine
WO2008094054A3 (fr) Composés
WO2009071691A3 (fr) Dérivés oxindoliques et leur utilisation comme médicament
MX2009005912A (es) Derivados de etilamina-fenilo heterociclilo sustituidos, su preparacion y uso como medicamentos.
WO2008050133A3 (fr) Inhibition d'une agrégation de beta-amyloïde
WO2009074498A8 (fr) Nouvelle utilisation médicale de l'orotate de propionate de 3-(2,2,2-triméthylhydrazine)
WO2005112923A3 (fr) Dérivés de 5-anilino-4-hétéroarylpyrazole utiles pour le traitement du diabete

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07820456

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: "NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC, EPO FORM 1205A DATED 07.07.09"

122 Ep: pct application non-entry in european phase

Ref document number: 07820456

Country of ref document: EP

Kind code of ref document: A2